And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on SGRY going forward to see if this recent jump can ...

However, SGRY expects those costs to significantly abate in 2025. This stock has been on a roller coaster in recent months. The stock gapped lower following its Q3 miss. However, it gapped higher in ...

Healthcare company Surgery Partners (NASDAQ:SGRY) will be announcing earnings ... we’ve identified a relatively ...

Explore Surgery Partners stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for SGRY. Flywire Posts Downbeat Results, Joins Lemonade, Ginkgo Bioworks And Other ...

Surgery Partners (NASDAQ:SGRY – Get Free Report)‘s stock had its “outperform” rating restated by stock analysts at Royal Bank of Canada in a research report issued on Tuesday,Benzinga reports. They ...

In a report released yesterday, Ben Hendrix from RBC Capital maintained a Buy rating on Surgery Partners (SGRY – Research Report), with a price ...

corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of SGRY in relation to earlier this year.

Short interest in Surgery Partners Inc (NASDAQ:SGRY) increased during the last reporting ... to close out their positions without sending the stock sharply higher.

LFST LifeStance Health Group, Inc.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...